🇺🇸 FDA
Patent

US 9120790

Azaindoles useful as inhibitors of Janus kinases

granted A61KA61K31/506A61K31/517

Quick answer

US patent 9120790 (Azaindoles useful as inhibitors of Janus kinases) held by Vertex Pharmaceuticals Incorporated expires Mon Aug 27 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Sep 01 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 27 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
2
CPC classes
A61K, A61K31/506, A61K31/517, A61K31/53, A61K31/5377